These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23489359)

  • 1. Potential applications of designed ankyrin repeat proteins in diagnostics and therapeutics.
    Baumann MJ; Stadler BM; Vogel M
    Expert Opin Med Diagn; 2007 Nov; 1(3):409-21. PubMed ID: 23489359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DARPins: a true alternative to antibodies.
    Stumpp MT; Amstutz P
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DARPins: a new generation of protein therapeutics.
    Stumpp MT; Binz HK; Amstutz P
    Drug Discov Today; 2008 Aug; 13(15-16):695-701. PubMed ID: 18621567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases.
    Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A
    ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile double-functionalization of designed ankyrin repeat proteins using click and thiol chemistries.
    Simon M; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2012 Feb; 23(2):279-86. PubMed ID: 22188139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.
    Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A
    Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy.
    Plückthun A
    Annu Rev Pharmacol Toxicol; 2015; 55():489-511. PubMed ID: 25562645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DARPins Bioengineering and its Theranostic Approaches: Emerging Trends in Protein Engineering.
    Rasool M; Malik A; Hussain M; Haq KA; Butt K; Ashraf MAB; Naseer MI; Asif M; Shaikh R; Mustafa MZ; Alam Q; Rasool G; Ahmad W; Haque A; Kamal MA
    Curr Pharm Des; 2017; 23(11):1610-1615. PubMed ID: 27928961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed ankyrin repeat proteins as anti-idiotypic-binding molecules.
    Vogel M; Keller-Gautschi E; Baumann MJ; Amstutz P; Ruf C; Kricek F; Stadler BM
    Ann N Y Acad Sci; 2007 Aug; 1109():9-18. PubMed ID: 17785285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Application of Designed Ankyrin Repeat Proteins (DARPins) as Research Tools and Protein Therapeutics.
    Boersma YL
    Methods Mol Biol; 2018; 1798():307-327. PubMed ID: 29868969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries.
    Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A
    Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designed ankyrin repeat proteins (DARPins) from research to therapy.
    Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
    Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display.
    Steiner D; Forrer P; Plückthun A
    J Mol Biol; 2008 Oct; 382(5):1211-27. PubMed ID: 18706916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage.
    Eggel A; Baumann MJ; Amstutz P; Stadler BM; Vogel M
    J Mol Biol; 2009 Oct; 393(3):598-607. PubMed ID: 19683003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants for improved stability of designed ankyrin repeat proteins with a redesigned C-capping module.
    Kramer MA; Wetzel SK; Plückthun A; Mittl PR; Grütter MG
    J Mol Biol; 2010 Dec; 404(3):381-91. PubMed ID: 20851127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
    Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
    J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chaperone-assisted structure elucidation with DARPins.
    Mittl PR; Ernst P; Plückthun A
    Curr Opin Struct Biol; 2020 Feb; 60():93-100. PubMed ID: 31918361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residue-resolved stability of full-consensus ankyrin repeat proteins probed by NMR.
    Wetzel SK; Ewald C; Settanni G; Jurt S; Plückthun A; Zerbe O
    J Mol Biol; 2010 Sep; 402(1):241-58. PubMed ID: 20654623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperone-assisted crystallography with DARPins.
    Sennhauser G; Grütter MG
    Structure; 2008 Oct; 16(10):1443-53. PubMed ID: 18940601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARPins against a functional IgE epitope.
    Baumann MJ; Eggel A; Amstutz P; Stadler BM; Vogel M
    Immunol Lett; 2010 Oct; 133(2):78-84. PubMed ID: 20673836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.